SciELO Data

Metrics

12,505 Downloads

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Publication Year: 2023

1,091 to 1,100 of 1,452 Results

Figure_03.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 264.8 KB - MD5: b74e0409502d7b94235f5464b0aafd53 Figure_3 - Detailed heatmap on the immunoexpression results of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma (normoxic regions) cases, for the development of a glycolytic phenotype.
Figure_04.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 131.4 KB - MD5: 2a6220ce3d9bf7a69301eed2e11811e9 Figure_4 - Kaplan-Meier curve demonstrating 3-year disease-free survival based on HK2 (A), and 3-year overall survival based on HK2 (B) and CAIX (C) immunoexpression status (normoxic regions), and on the glycolytic phenotype (according to the number of positive biomarkers) of pat...
Figure_05.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 99.6 KB - MD5: 8771da16a24a957362d97f9b82a53dc0 Figure_5 - Immunoexpression of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA and MCT4 in normoxic versus hypoxic compartments of oral squamous cell carcinoma cases.
Figure_06.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 96.5 KB - MD5: 0bcb6a20ae60ab18463d1b04c6e10035 Figure_6 - Kaplan-Meier curve demonstrating 3-year overall survival based on GLUT1 (A) and GLUT3 (B), and 3-year disease-free survival based on HK2 (C) immunoexpression status (hypoxic regions) of patients with oral squamous cell carcinoma.
Figure_S01.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 234.9 KB - MD5: ff0fcb57d0fc460985126d63b66178e9 Figure_S1 - Grading system used for the evaluation of immunohistochemistry results.
Figure_S02.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 262.9 KB - MD5: 12ae6668a4ef9199afd79840616fe1fe Figure_S2 - Representative images of the immunohistochemical staining reactions for GLUT1 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell...
Figure_S03.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 305.8 KB - MD5: a1e311c55507df1acdd7ec27dc45b541 Figure_S3 - Representative images of the immunohistochemical staining reactions for GLUT3 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell...
Figure_S04.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 384.8 KB - MD5: a7777f63c12b239774ca335cac6a3570 Figure_S4 - Representative images of the immunohistochemical staining reactions for HK2 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell ca...
Figure_S05.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 386.6 KB - MD5: a9d95f2e12e85d8f8fb637ccc6a92b40 Figure_S5 - Representative images of the immunohistochemical staining reactions for PFKL in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell c...
Figure_S06.jpg Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study JPEG Image - 380.8 KB - MD5: 740489343795404373f10c0b35326688 Figure_S6 - Representative images of the immunohistochemical staining reactions for PKM2 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell c...

Figure_03.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 264.8 KB -

Figure_3 - Detailed heatmap on the immunoexpression results of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma (normoxic regions) cases, for the development of a glycolytic phenotype.

Figure_04.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 131.4 KB -

Figure_4 - Kaplan-Meier curve demonstrating 3-year disease-free survival based on HK2 (A), and 3-year overall survival based on HK2 (B) and CAIX (C) immunoexpression status (normoxic regions), and on the glycolytic phenotype (according to the number of positive biomarkers) of pat...

Figure_05.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 99.6 KB -

Figure_5 - Immunoexpression of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA and MCT4 in normoxic versus hypoxic compartments of oral squamous cell carcinoma cases.

Figure_06.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 96.5 KB -

Figure_6 - Kaplan-Meier curve demonstrating 3-year overall survival based on GLUT1 (A) and GLUT3 (B), and 3-year disease-free survival based on HK2 (C) immunoexpression status (hypoxic regions) of patients with oral squamous cell carcinoma.

Figure_S01.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 234.9 KB -

Figure_S1 - Grading system used for the evaluation of immunohistochemistry results.

Figure_S02.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 262.9 KB -

Figure_S2 - Representative images of the immunohistochemical staining reactions for GLUT1 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell...

Figure_S03.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 305.8 KB -

Figure_S3 - Representative images of the immunohistochemical staining reactions for GLUT3 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell...

Figure_S04.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 384.8 KB -

Figure_S4 - Representative images of the immunohistochemical staining reactions for HK2 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell ca...

Figure_S05.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 386.6 KB -

Figure_S5 - Representative images of the immunohistochemical staining reactions for PFKL in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell c...

Figure_S06.jpg

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

JPEG Image - 380.8 KB -

Figure_S6 - Representative images of the immunohistochemical staining reactions for PKM2 in white oral lichen planus (A), oral leukoplakia without dysplasia (B), oral leukoplakia with low grade dysplasia (C), oral leukoplakia with high grade dysplasia (D) and oral squamous cell c...

Add Data

Share Dataverse

Link Dataverse

Reset Modifications